Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity. [electronic resource] by
- Ribas, A
- Albanell, J
- Bellmunt, J
- Solé-Calvo, L A
- Bermejo, B
- Gallardo, E
- Vidal, R
- Vera, R
- Eres, N
- Carulla, J
- Baselga, J
Producer: 19960618
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14
Availability: No items available.
|
|
13.
|
Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis. [electronic resource] by
- Albanell, J
- Bellmunt, J
- Molina, R
- García, M
- Caragol, I
- Bermejo, B
- Ribas, A
- Carulla, J
- Gallego, O S
- Español, T
- Solé Calvo, L A
Producer: 19960821
In:
Anticancer research vol. 16
Availability: No items available.
|
|
14.
|
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI). [electronic resource] by
- Ribas, A
- Bellmunt, J
- Albanell, J
- De Torres, I
- Bermejo, B
- De Torres, J A
- Morote, J
- Gallardo, E
- Vera, R
- Carulla, J
- Sole-Calvo, L A
Producer: 19970328
In:
Tumori vol. 82
Availability: No items available.
|
|
15.
|
[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)]. [electronic resource] by
- Bellmunt Molins, J
- Ribas, A
- Albanell, J
- Lorente Garín, J A
- de Torres Mateos, J A
- Morote Robles, J
- López Palacios, M A
- Banús Gassol, J M
- Casado Cobo, S
- Eres, N
- Solé Calvo, L A
Producer: 19961217
In:
Archivos espanoles de urologia vol. 49
Availability: No items available.
|